Outcomes among patients admitted for non-ST-segment myocardial infarction in the pre-pandemic and pandemic COVID-19 era: Israel Nationwide study.
Elad AsherAlexander FardmanHezzy ShmueliKatia OrvinDaniel OrenNatalia KofmanJameel MohsenGassan MoadyLouay TahaRonen RubinshteinOsherov AzrielRoi EfraimDabbah SaleemPhilippe TaiebEyal Ben-AssaTal CohenRobert KlempfnerAmir OrlevRoy BeigelAmit SegevShlomi MatetzkyPublished in: International journal for quality in health care : journal of the International Society for Quality in Health Care (2022)
In contrast to previous reports, admission rates of NSTEMI were similar in this nationwide survey during the COVID-19 era. With longer time from symptoms to admission, but with the same time from hospital admission to reperfusion therapy and with similar in-hospital and 30-day mortality rates. Even in times of crisis, adherence of medical systems to clinical practice guidelines ensures the preservation of good clinical outcomes.
Keyphrases
- coronavirus disease
- sars cov
- emergency department
- healthcare
- adverse drug
- respiratory syndrome coronavirus
- heart failure
- public health
- acute myocardial infarction
- cerebral ischemia
- cardiovascular events
- risk factors
- metabolic syndrome
- physical activity
- adipose tissue
- cardiovascular disease
- stem cells
- magnetic resonance imaging
- depressive symptoms
- contrast enhanced
- mesenchymal stem cells
- acute coronary syndrome